A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 270 participants.
Also called NCT02091362
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose basic science
- Phase
- Phase 2
- Enrolled
- 270 participants
- Sponsor
- Registry
-
NCT02091362 -
2013-003834-33
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Czechia, Mexico, Poland, Puerto Rico
- Registry status
- Completed
Technical summary
Registry record NCT02091362. Randomized; triple masking; primary purpose basic science. Start 2014-03 (registry gives no type); primary completion 2015-01 (actual). Results posted on 2018-07-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- LY2409021
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Metformin
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct02091362- Content hash
f8c58771b48483492def749392a9070c1682c7cfdf645decffb186e9a01508a4